Multiple Sclerosis Clinical Trials in Phoenix

Showing 501-520 of 574 trials

Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

NCT00195260

To evaluate the safety and tolerability of oral SKI-606 (bosutinib) administered on a daily schedule to subjects with advanced malignant solid tumors and to define a maximum tolerated dose (MTD) in this subject population.

Neoplasms

Pfizer151 participantsStarted Oct 2004

Birmington, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +16 more locations

COMPLETEDPhase 3100 miles

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

NCT00373256

To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus paclitaxel to determine which treatment works better against breast cancer

Breast Neoplasms

Pfizer488 participantsStarted Nov 2006

Bessemer, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +247 more locations

Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Multiple Sclerosis Trials in Other Cities

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

Other Conditions in Phoenix